SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    J. E. Eaton, B. D. Juran, E. J. Atkinson, E. M. Schlicht, X. Xie, M. Andrade, C. S. Lammert, V. A. Luketic, J. A. Odin, A. A. Koteish, K. V. Kowdley, K. B. Chopra, G. M. Hirschfield, N. P. Chalasani, K. N. Lazaridis, A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2015, 41, 10
  2. 2
    John E Eaton, Emily G Barr Fritcher, Gregory J Gores, Elizabeth J Atkinson, James H Tabibian, Mark D Topazian, Andrea A Gossard, Kevin C Halling, Benjamin R Kipp, Konstantinos N Lazaridis, Biliary Multifocal Chromosomal Polysomy and Cholangiocarcinoma in Primary Sclerosing Cholangitis, The American Journal of Gastroenterology, 2015, 110, 2, 299

    CrossRef

  3. 3
    Elisabeth M.G. de Vries, Ulrich Beuers, Cyriel Y. Ponsioen, Biomarkers for disease progression of primary sclerosing cholangitis, Current Opinion in Gastroenterology, 2015, 31, 3, 239

    CrossRef

  4. You have free access to this content4
    Atsushi Tanaka, Susumu Tazuma, Kazuichi Okazaki, Hirohito Tsubouchi, Kazuo Inui, Hajime Takikawa, Clinical profiles of patients with primary sclerosing cholangitis in the elderly, Journal of Hepato-Biliary-Pancreatic Sciences, 2015, 22, 3
  5. 5
    Pia Manninen, Anna-Liisa Karvonen, Johanna Laukkarinen, Petri Aitola, Heini Huhtala, Pekka Collin, Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease, Scandinavian Journal of Gastroenterology, 2015, 50, 4, 423

    CrossRef

  6. 6
    K. D. Williamson, R. W. Chapman, Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC, Alimentary Pharmacology & Therapeutics, 2015, 41, 1
  7. 7
    Juan González-Moreno, Inés Losada López, Norberto Ortego Centeno, Enfermedad relacionada con IgG4, Medicina Clínica, 2015,

    CrossRef

  8. 8
    Annika Bergquist, Erik von Seth, Epidemiology of Cholangiocarcinoma, Best Practice & Research Clinical Gastroenterology, 2015,

    CrossRef

  9. 9
    Johanna Haapamäki, Andrea Tenca, Harri Sintonen, Nina Barner-Rasmussen, Martti A. Färkkilä, Health-related quality of life among patients with primary sclerosing cholangitis, Liver International, 2015, 35, 5
  10. 10
    T.J. Weismüller, T.O. Lankisch, T. Voigtländer, Kolonkarzinom und Gallengangskarzinom bei primär sklerosierender Cholangitis, Der Gastroenterologe, 2015, 10, 1, 26

    CrossRef

  11. 11
    Monika Sarkar, Kymberly D. Watt, Norah Terrault, Marina Berenguer, Outcomes in liver transplantation: Does sex matter?, Journal of Hepatology, 2015, 62, 4, 946

    CrossRef

  12. 12
    H. Yanai, S. Matalon, A. Rosenblatt, H. Awadie, T. Berdichevski, Y. Snir, U. Kopylov, L. Katz, A. Stein, L. Mlynarsky, H. Tulchinsky, F. M. Konikoff, S. Ben Horin, M. Braun, Z. Ben-Ari, Y. Chowers, Y. Baruch, O. Shibolet, I. Dotan, Prognosis of Primary Sclerosing Cholangitis in Israel is Independent of Coexisting Inflammatory Bowel Disease, Journal of Crohn's and Colitis, 2015, 9, 2, 177

    CrossRef

  13. 13
    Saira A. Khaderi, Norman L. Sussman, Screening for Malignancy in Primary Sclerosing Cholangitis (PSC), Current Gastroenterology Reports, 2015, 17, 4

    CrossRef

  14. You have free access to this content14
    Nir Lubezky, Marcelo Facciuto, Norifumi Harimoto, Myron E. Schwartz, Sander S. Florman, Surgical treatment of intrahepatic cholangiocarcinoma in the USA, Journal of Hepato-Biliary-Pancreatic Sciences, 2015, 22, 2
  15. 15
    N. G. Rossen, S. Fuentes, K. Boonstra, G. R. D'Haens, H. G. Heilig, E. G. Zoetendal, W. M. de Vos, C. Y. Ponsioen, The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II, Journal of Crohn's and Colitis, 2015, 9, 4, 342

    CrossRef

  16. 16
    María E. Negrón, Gilaad G. Kaplan, Herman W. Barkema, Bertus Eksteen, Fiona Clement, Braden J. Manns, Stephanie Coward, Remo Panaccione, Subrata Ghosh, Steven J. Heitman, Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis, Inflammatory Bowel Diseases, 2014, 20, 11, 2046

    CrossRef

  17. 17
    Andres J. Yarur, Frank Czul, Cynthia Levy, Hepatobiliary Manifestations of Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 2014, 20, 9, 1655

    CrossRef

  18. 18
    Roman Zenouzi, Tobias J. Weismüller, Peter Hübener, Kornelius Schulze, Michael Bubenheim, Nadine Pannicke, Christina Weiler–Normann, Henrike Lenzen, Michael P. Manns, Ansgar W. Lohse, Christoph Schramm, Low Risk of Hepatocellular Carcinoma in Patients With Primary Sclerosing Cholangitis With Cirrhosis, Clinical Gastroenterology and Hepatology, 2014, 12, 10, 1733

    CrossRef

  19. 19
    Raj Vuppalanchi, Keith Lindor, Magic Wand and Crystal Ball for Primary Sclerosing Cholangitis, Gastroenterology, 2014, 146, 4, 890

    CrossRef

  20. You have free access to this content20
    Roger W. Chapman, Malignancy in primary sclerosing cholangitis: Bile duct, liver, and colon, Clinical Liver Disease, 2014, 3, 4
  21. You have free access to this content21
    Atsushi Tanaka, Susumu Tazuma, Kazuichi Okazaki, Hirohito Tsubouchi, Kazuo Inui, Hajime Takikawa, Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan, Journal of Hepato-Biliary-Pancreatic Sciences, 2014, 21, 1
  22. You have free access to this content22
    Christopher L. Bowlus, Primary sclerosing cholangitis: One disease or several?, Clinical Liver Disease, 2014, 3, 2
  23. 23
    Hanno Ehlken, Christoph Schramm, PSC: Novel disease associations providing pathogenetic clues?, Journal of Hepatology, 2014, 60, 4, 687

    CrossRef

  24. 24
    C. Rupp, A. Rössler, E. Halibasic, P. Sauer, K.-H. Weiss, K. Friedrich, A. Wannhoff, A. Stiehl, W. Stremmel, M. Trauner, D. N. Gotthardt, Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis, Alimentary Pharmacology & Therapeutics, 2014, 40, 11-12
  25. 25
    T. H. Karlsen, M. Vesterhus, K. M. Boberg, Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 3
  26. 26
    Christian Rupp, Konrad Bode, Fadi Chahoud, Andreas Wannhoff, Kilian Friedrich, Karl-Heinz Weiss, Peter Sauer, Wolfgang Stremmel, Daniel Gotthardt, Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis, BMC Infectious Diseases, 2014, 14, 1, 562

    CrossRef

  27. 27
    Kirsten Boonstra, Emma L. Culver, Lucas Maillette de Buy Wenniger, Marianne J. Heerde, Karel J. Erpecum, Alexander C. Poen, Karin M.J. Nieuwkerk, B.W. Marcel Spanier, Ben J.M. Witteman, Hans A.R.E. Tuynman, Nan Geloven, Henk Buuren, Roger W. Chapman, Eleanor Barnes, Ulrich Beuers, Cyriel Y. Ponsioen, Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis, Hepatology, 2014, 59, 5
  28. 28
    Pilar Brito-Zerón, Manuel Ramos-Casals, Xavier Bosch, John H. Stone, The clinical spectrum of IgG4-related disease, Autoimmunity Reviews, 2014, 13, 12, 1203

    CrossRef

  29. 29
    Atsushi Tanaka, Hajime Takikawa, Geoepidemiology of primary sclerosing cholangitis: A critical review, Journal of Autoimmunity, 2013, 46, 35

    CrossRef